Search research articles
Contact Us
Filters
Showing results (111-120 of 130) with videos related to
Page
of 13
Sort By:
Journal of Public Health in Africa
|
November 29, 2023
Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era
Willy LE Roi Togna Pabo, Debimeh Njume, Roland Ndip Ndip, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 17, 2012
Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognition
John Skidmore, Zeenat Atcha, Emmanuelle Boucherat, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 17, 2012
The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement
John Skidmore, Zeenat Atcha, Emmanuelle Boucherat, et al.
Antimicrobial Resistance and Infection Control
|
August 27, 2020
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
Joseph Fokam, Desire Takou, Ezechiel Ngoufack Jagni Semengue, et al.
The Journal of Pediatrics
|
January 18, 2024
Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV Cure
Aude Christelle Ka'e, Maria Mercedes Santoro, Aubin Nanfack, et al.
Journal of Public Health in Africa
|
June 20, 2022
High concordance in SARSCoV-2 detection between automated (<i>Abbott m2000</i>) and manual (<i>DaAn gene</i>) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon
Nadine Nguendjoung Fainguem, Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, et al.
Frontiers in Medicine
|
October 7, 2024
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study
Willy Le Roi Togna Pabo, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
Viruses
|
January 21, 2023
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
Ezechiel Ngoufack Jagni Semengue, Joseph Fokam, Naomi-Karell Etame, et al.
Scientific Reports
|
January 13, 2026
Hepatitis B immune escape and drug resistance mutations among blood donors in Gabon during the year 2022
Denis Maulot-Bangola, Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, et al.
Microbiology Spectrum
|
October 19, 2022
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, Evariste Molimbou, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 130) with videos related to
Sort By:
Page
of 13
Journal of Public Health in Africa
|
November 29, 2023
Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era
Willy LE Roi Togna Pabo, Debimeh Njume, Roland Ndip Ndip, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 17, 2012
Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognition
John Skidmore, Zeenat Atcha, Emmanuelle Boucherat, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 17, 2012
The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement
John Skidmore, Zeenat Atcha, Emmanuelle Boucherat, et al.
Antimicrobial Resistance and Infection Control
|
August 27, 2020
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
Joseph Fokam, Desire Takou, Ezechiel Ngoufack Jagni Semengue, et al.
The Journal of Pediatrics
|
January 18, 2024
Characterization of HIV-1 Reservoirs in Children and Adolescents: A Systematic Review and Meta-Analysis Toward Pediatric HIV Cure
Aude Christelle Ka'e, Maria Mercedes Santoro, Aubin Nanfack, et al.
Journal of Public Health in Africa
|
June 20, 2022
High concordance in SARSCoV-2 detection between automated (<i>Abbott m2000</i>) and manual (<i>DaAn gene</i>) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon
Nadine Nguendjoung Fainguem, Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, et al.
Frontiers in Medicine
|
October 7, 2024
Empowering adolescents living with perinatally-acquired HIV: tailored CD4+ count assessment for optimized care, the EDCTP READY-study
Willy Le Roi Togna Pabo, Aurelie Minelle Kengni Ngueko, Alex Durand Nka, et al.
Viruses
|
January 21, 2023
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
Ezechiel Ngoufack Jagni Semengue, Joseph Fokam, Naomi-Karell Etame, et al.
Scientific Reports
|
January 13, 2026
Hepatitis B immune escape and drug resistance mutations among blood donors in Gabon during the year 2022
Denis Maulot-Bangola, Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, et al.
Microbiology Spectrum
|
October 19, 2022
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, Evariste Molimbou, et al.
Page
of 13